I run a pooled CRISPR knockout screen targeting glycosylation genes to understand how host-cell glycosylation shapes the production, cargo loading, and cellular uptake of lentivirus-derived nanoparticles (LVNPs) — engineered particles used to deliver Cas9/sgRNA complexes to target cells.
In collaboration with Aarhus University Hospital (AUH), I also work on developing prime editing–based correction strategies for Wilson disease, a genetic disorder of copper metabolism.